These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 19729934)

  • 21. Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis.
    Siegel G; Schäfer P; Winkler K; Malmsten M
    Wien Med Wochenschr; 2007; 157(13-14):288-94. PubMed ID: 17704974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
    Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
    Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC; D'Agostino RB; Haffner SM; Otvos JD
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia.
    Carrero JJ; Baró L; Fonollá J; González-Santiago M; Martínez-Férez A; Castillo R; Jiménez J; Boza JJ; López-Huertas E
    Nutrition; 2004 Jun; 20(6):521-7. PubMed ID: 15165614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.
    Maki KC; McKenney JM; Reeves MS; Lubin BC; Dicklin MR
    Am J Cardiol; 2008 Aug; 102(4):429-33. PubMed ID: 18678300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
    Nordøy A; Hansen JB; Brox J; Svensson B
    Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):7-16. PubMed ID: 11383326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects of conjugated linoleic acids supplementation on circulating lipoprotein (a) levels in overweight and obese individuals: results of a systematic review and meta-analysis of randomized controlled trials.
    Leilami K; Kohansal A; Mohammadi Sartang M; Babajafari S; Sohrabi Z
    Am J Cardiovasc Dis; 2021; 11(1):124-135. PubMed ID: 33815928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance.
    Siegel G; Malmsten M; Ermilov E
    Adv Colloid Interface Sci; 2014 Mar; 205():275-318. PubMed ID: 24534475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of arteriosclerotic nanoplaque formation and size by n-3 fatty acids in patients after valvular defect operation.
    Koppe C; Rodríguez M; Winkler K; Pietzsch J; Neumann K; Hiemann NE; Hetzer R; Malmsten M; Siegel G
    Forsch Komplementmed; 2009 Aug; 16(4):237-45. PubMed ID: 19729934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.
    Rodríguez M; Ringstad L; Schäfer P; Just S; Hofer HW; Malmsten M; Siegel G
    Atherosclerosis; 2007 Jun; 192(2):438-44. PubMed ID: 17397850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of garlic on arteriosclerotic nanoplaque formation and size.
    Siegel G; Malmsten M; Pietzsch J; Schmidt A; Buddecke E; Michel F; Ploch M; Schneider W
    Phytomedicine; 2004 Jan; 11(1):24-35. PubMed ID: 14971718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor.
    Abletshauser C; Klüssendorf D; Schmidt A; Winkler K; März W; Buddecke E; Malmsten M; Siegel G
    Acta Physiol Scand; 2002 Oct; 176(2):131-45. PubMed ID: 12354173
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.